# iShares Biotechnology ETF (IBB)

> Source: Nexqual · https://nexqual.com/IBB · data as of 2026-10-21 19:38 UTC · cite as "Nexqual, iShares Biotechnology ETF (IBB), nexqual.com/IBB" · informational, not investment advice.

**Price:** USD 212.44 (+0.92% today) · US market open, as of October 21, 2026 at 19:38 UTC; quotes may be delayed. Prev close 210.5 · day 210.18–213.3 · 52w 153.25–217.12 · market cap null · NGM

## Key facts
- Total return with dividends: 1Y +36.4% vs S&P 500 +16.4%; 5Y +35.8% vs S&P 500 +82.4%.

## Total return (dividends reinvested)
|  | 1Y (from 2025-10-21) | 5Y (from 2021-10-18) |
|---|---|---|
| Total return | +36.4% | +35.8% |
| S&P 500 (SPY) | +16.4% | +82.4% |
| Per year | +36.5% | +6.3% |
| Volatility (annualized) | 22.6% | 21.6% |
| Max drawdown | -9.6% (Jan 2026→Mar 2026) | -31.3% (Oct 2021→Jun 2022) |

## Peers
XBI (State Street SPDR S&P Biotech E) USD 153.33 +0.06% · XLV (State Street Health Care Select) USD 178.98 -0.47% · XLF (State Street Financial Select S) USD 55.97 +0.45% · XLE (State Street Energy Select Sect) USD 68.21 +0.35% · XLK (State Street Technology Select ) USD 188.59 +1.70%

## More
Full page: https://nexqual.com/IBB · Free keyless MCP server with the same data and citations: https://mcp.nexqual.com/mcp · Guide for agents: https://nexqual.com/agents · https://nexqual.com/llms.txt

## Options: expected move (Cboe, 15-min delayed)

| Expiration | Days | ATM IV | Expected move |
|---|---|---|---|
| 2026-11-20 | 30 | 24.8% | ±5.8% |
| 2026-12-18 | 58 | 25.8% | ±8.3% |
| 2027-01-15 | 86 | 24.9% | ±9.7% |
| 2027-03-19 | 149 | 23.7% | ±12.1% |
| 2027-05-21 | 212 | 25.5% | ±15.5% |
| 2027-06-17 | 239 | 26.4% | ±17.1% |
| 2027-08-20 | 303 | 24.9% | ±18.1% |
| 2027-09-17 | 331 | 25.7% | ±19.6% |